Abstracts in high profile journals often fail to report harm

BMC Medical Research Methodology

Volumn 8, Issue , 2008, Pages

  Bernal Delgado, Enrique ^a   Fisher, Elliot S ^b  

^a INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CORRECTED PREVALENCE RATIO; DRUG INDUSTRY; LOGISTIC REGRESSION ANALYSIS; MEDICAL LITERATURE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STRUCTURED INTERVIEW; BIBLIOMETRICS; DOCUMENTATION; HUMAN; IATROGENIC DISEASE; INFORMATION RETRIEVAL; LETTER; METHODOLOGY; PUBLICATION; STANDARD; STATISTICAL MODEL;

ABSTRACTING AND INDEXING AS TOPIC; BIBLIOMETRICS; CONFIDENCE INTERVALS; HUMANS; IATROGENIC DISEASE; INFORMATION STORAGE AND RETRIEVAL; LOGISTIC MODELS; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 42549141336     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-8-14     Document Type: Article

References (25)

1. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. JM Stern RJ Simes, BMJ 1997 315 640 5 9310565
2. Empirical evidence for selective reporting of outcomes in randomized trials. AW Chan A Hróbjartsson MT Haahr PC Gotzsche DG Altman, JAMA 2004 291 2457 2465 10.1001/jama.291.20.2457 15161896
3. Are benefits and harm in mammography screening given equal attention in scientific articles? A cross sectional study. KJ Jørgensen A Klahn PC Gøtzsche, BMC Medicine 2007 5 12 17537243 10.1186/1741-7015-5-12
4. A study of manufacturer-supported trials of non-steroidal anti-inflammatory drugs in the treatment of arthritis. PA Rochon JH Gwrwitz PR Fortin DT Felson KL Minaker TC Chalmers, Arch Intern Med 1994 154 157 63 10.1001/archinte.154.2.157 8285810
5. Scope and impact of financial conflicts of interest in biomedical research. JE Bekelman Y Li CP Gross, JAMA 2003 289 454 65 10.1001/jama.289.4.454 12533125
6. Relationship between conflicts of interest and research results. LS Friedman ED Ritcher, J Gen Intern Med 2004 19 51 6 14748860 10.1111/j.1525-1497. 2004.30617.x
7. Conflict of interest in the debate over calcium-channel antagonists. HT Stelfox Ch Grace K O'Rourke AS Detsky, NEJM 1998 338 101 6 10.1056/ NEJM199801083380206 9420342
8. Reporting of adverse drug reactions in randomised controlled trials - a systematic review. YK Loke S Derry, BMC Clinical Pharmacology 2001 1 3 11591227 10.1186/1472-6904-1-3
9. Completeness of safety reporting in Randomized Trials. JPA Ioannidis J Lau, JAMA 2001 285 437 443 10.1001/jama.285.4.437 11242428
10. Identifying outcome reporting bias in randomised trials on Pubmed: review of publications and survey of authors. AW Chan DG Altman, BMJ 2005 330 753 15681569 10.1136/bmj.38356.424606.8F
11. Absolutely Relative: How research results are summarized can affect treatment decisions. L Forrow WC Taylor RM Arnold, Am J Med 1992 92 121 124 10.1016/0002-9343(92)90100-P 1543193
12. Completeness of reporting trial results: effect on physicians'willingness to prescribe. M Bobbio B Demichelis G Giustetto, Lancet 1994 343 1209 11 10.1016/S0140-6736(94)92407-4 7909875
13. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. HC Bucher M Weynbacher K Gyr, BMJ 1994 309 761 4 7950558
14. Impact of presentation of research results on likelihood of prescribing medications to patients with left ventricular dysfunction. CR Lacy JA Barone DC Suh PL Malini M Bueno DM Moylan, Am J Cardiol 2001 87 203 7 10.1016/S0002- 9149(00)01317-5 11152840
15. Influencia de la presentación de los ensayos clínicos en la intención de prescribir: relativizando el riesgo relativo. S Marquez R Meneu S Peiró Aten Primaria 1998 21 446 50 9656582
16. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? CD Naylor E Chen B Strauss, Ann Intern Medicine 1992 117 916 21
17. Family Physicians' use of medical abstracts to guide decision making: style or substance? HC Barry MH Ebell AF Shaughnessy C David F Neitzke, J Am Board Fam Practice 2001 14 437 42
18. Better reporting of randomized trials in biomedical journal and conference abstracts. S Hopewell A Eisinga M Clarke, Journal of Information Science 2008 34 162 173 10.1177/0165551507080415
19. Quality of reporting of randomized clinical trials in abstracts of the 2005 annual meeting of the American college of Rheumatology. CL Hill R Buchbinder R Osborne, J Rheumatol 2007 34 2476 2480 17985398
20. The reporting quality of abstracts of randomized controlled trials submitted to the ICS meeting in Heidelberg. P Herbison, Neurourology and Urodynamics 2005 24 21 24 10.1002/nau.20076
21. Better reporting of harm in randomized trials: an extension of the CONSORT statement. JA Ioannidis SJ Evans PC Gtzsche RT O'Neill DG Altman K Schulz for the CONSORT group, Ann Intern Med 2004 141 781 8 15545678
22. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. S Hopewell M Clarke D Moher E Wager P Middleton DG Altman KF Schulz the CONSORT Group, PLoS Med 2008 5 e20 18215107 10.1371/journal.pmed.0050020
23. CONSORT for reporting randomised trials in journal and conference abstracts. S Hopewell M Clarke D Moher E Wager P Middleton DG Altman KF Schulz the CONSORT Group, Lancet 2008 371 281 283 10.1016/S0140-6736(07)61835-2 18221781
24. What's the relative risk? A method of correcting the Odds Ratio in cohort studies of common outcomes. J Zhang FY Kai, JAMA 1998 280 1690 1 10.1001/jama.280.19.1690 9832001
25. Odds Ratio or Relative Risk for cross-sectional data? J Lee, Int J Epidemiol 1994 23 201 3 10.1093/ije/23.1.201 8194918